Our ambition at Vivatum is to modernise the delivery of peritoneal dialysis by integrating intelligent software with user-friendly hardware.
In Conversation
We exist to serve patients for whom no other options are available. That purpose is what drives us, and what defines the way we do business.
MoonLake represents a deliberate challenge to conventional biotech wisdom across multiple dimensions.
Digital pathology creates unprecedented opportunities for AI in cancer care.
Technologies enabling oral biologics development will become increasingly valuable as pharmaceutical companies recognize the commercial imperative for accessible, cost-effective alternatives to current injectable therapies.
Our job is to make solutions so compelling that people want to wear them, and to ensure hearing health is seen not as a luxury, but…
We must remember that behind every result is a person waiting for answers, and that is ultimately where our focus lies: enabling clinicians to make better…
Manufacturing is no longer an afterthought; it is a competitive differentiator.
If Europe can consistently bring that expertise to bear at the right time, it will increase the likelihood of success and position companies for more sustainable…
The combination of Switzerland's pharmaceutical excellence, our global connectivity, and advanced AI capabilities positions us to lead industry transformation initiatives that will define the next decade…
The ophthalmology sector has experienced significant capital influx following the emergence of several blockbuster treatments that demonstrated substantial commercial viability.
The healthcare sector's industrial vitality directly supports our broader healthcare system objectives, creating a virtuous cycle that benefits both economic competitiveness and public health outcomes.
